Inventor · disambiguated record
Mona Patel
Also filed as: PATEL MONA
20 granted patents·4 pending applications·161 citations·filing 1997–2009
93Inventor score
Files withJANSSEN PHARMACEUTICA NV11DU PONT PHARM CO4BRISTOL MYERS SQUIBB PHARMA CO2BEAVERS MARY PAT1BRISTOL MYERS SQUIBB PHARMA1
Top patents by PatentIndex Score
24 records- 0194US7511022B2Substituted indole-O-glucosidesJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Mar 31, 2009·27 cites·14 claims
- 0294US5874430A4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the sameDU PONT PHARM CO·Filed 1997·Granted Feb 23, 1999·87 cites·22 claims
- 0383US7129220B2Substituted indole-O-glucosidesJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Oct 31, 2006·13 cites·21 claims
- 0481US7511021B2Substituted indazole-O-glucosidesJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Mar 31, 2009·3 cites·15 claims
- 0581US7084124B2Substituted indazole-O-glucosidesJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Aug 1, 2006·9 cites·20 claims
- 0673US6593337B1Tricyclic compounds useful as HIV reverse transcriptase inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Jul 15, 2003·3 cites·53 claims
- 0772US7531671B2Dihydroisoindolones as allosteric modulators of glucokinaseJANSSEN PHARMACEUTICA NV·Filed 2006·Granted May 12, 2009·2 cites·23 claims
- 0871US7687494B2Substituted spirobenzazepinesJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Mar 30, 2010·1 cites·22 claims
- 0969US7825110B2Substituted spiroheterocyclesJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Nov 2, 2010·1 cites·25 claims
- 1069US7820630B2Substituted indole-O-glucosidesJANSSEN PHARMACEUTICA NV·Filed 2009·Granted Oct 26, 2010·0 cites·13 claims
- 1169US7816331B2Substituted indazole-O-glucosidesJANSSEN PHARMACEUTICA NV·Filed 2009·Granted Oct 19, 2010·0 cites·14 claims
- 1265US2009105164A1Substituted indole-o-glucosidesBEAVERS MARY PAT·Filed 2008·Application pending·0 cites
- 1364US2009099104A1Substituted indazoles-o- glucosidesPATEL MONA·Filed 2008·Application pending·0 cites
- 1461US6492515B24,4-disubstituted-1, 4-dihydro-2H-3, 1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the sameBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Dec 10, 2002·1 cites·4 claims
- 1557US7928246B2Dihydroisoindolones as allosteric modulators of glucokinaseJANSSEN PHARMACEUTICA NV·Filed 2009·Granted Apr 19, 2011·0 cites·1 claims
- 1651US6225317B1Crystalline (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-3,4-dihydro-2(1H)-quinazolinoneDU PONT PHARM CO·Filed 1999·Granted May 1, 2001·5 cites·24 claims
- 1750US2004002498A1Tricyclic compounds useful as HIV reverse transcriptase inhibitorsFiled 2003·Application pending·0 cites
- 1849US2004266752A1Substituted spirobenzazepinesFiled 2004·Application pending·0 cites
- 1947US7825111B2Substituted spiroheterocyclesJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Nov 2, 2010·0 cites·26 claims
- 2047US6303780B14,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the sameDU PONT PHARM CO·Filed 2000·Granted Oct 16, 2001·0 cites·9 claims
- 2145US6265406B1Substituted quinolin-2 (1H) -ones useful as HIV reverse transcriptase inhibitorsDU PONT PHARM CO·Filed 2000·Granted Jul 24, 2001·3 cites·16 claims
- 2245US6090821ASubstituted quinolin-2 (1H)-ones useful as HIV reverse transcriptase inhibitorsDU PONT·Filed 1999·Granted Jul 18, 2000·6 cites·15 claims
- 2342US6969721B2Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitorsBRISTOL MYERS SQUIBB PHARMA·Filed 2003·Granted Nov 29, 2005·0 cites·12 claims
- 2431US6596729B2Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitorsSQUIBB BRISTOL MYERS PHARMA CO·Filed 2001·Granted Jul 22, 2003·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Mona Patel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →